Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

A multinational research group has been the first to show the excellent activity of artemisinin-based treatment against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cell lines – including a specific type of lung cells. Their findings were recently published in the journal Scientific Reports.

Dried leaf Artemisia annua efficacy against non-small cell lung cancer - ScienceDirect

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Researchers evaluate artemisinin for COVID-19 management

In vitro efficacy of Artemisia extracts against SARS-CoV-2

Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19), BMC Complementary Medicine and Therapies

Coronavirus (COVID-19) Alternative Treatment and Prevention

Treatment efficacy of extracts and compounds against SARS-CoV-2 in a

Frontiers A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review

Early Research Finds Extracts from Sweet Wormwood Plant Can Inhibit the COVID-19 Virus

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Viruses, Free Full-Text

Cape Town Farmacy

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Antibiotics, Free Full-Text